Researchers at Vanderbilt University have found a new way to “dissect” the human immune response following influenza vaccination.

A study appearing in the January edition of Pediatrics, led by researchers at Vanderbilt University Medical Center, looks at how Nashville children ages 6 months through 5 years fared over 11 consecutive flu seasons concluding in 2010-11.

Less than 10 seconds – that’s as long as it takes to roll up your sleeve and be part of Wednesday's Flulapalooza, Vanderbilt University Medical Center’s mass flu vaccination event.

Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination event that three years ago more than doubled the current world record for the total number of vaccinations given in an eight-hour period.

Compounds developed at Vanderbilt University may offer a new way to block influenza infection.

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.